Sleep Apnea Devices Market

Publisher Roots Analysis

Published Feb 01, 2024

Length 310 Pages

SKU # ROAL18576019

Description

Sleep Apnea Devices Market

Sleep Apnea Devices Market, Industry Trends and Global Forecasts, till 2035 - Distribution by Product Type (Sleep Apnea Medical Devices and Drug Therapies), Type of Diagnostic Device (Polysomnography Devices and Home Sleep Apnea Testing Devices), Type of Therapeutic Device (Positive Airway Pressure Devices, Oral Devices and Implantable Devices), Type of Positive Airway Pressure Device (CPAP Machine, BiPAP, APAP and Other Devices), Route of Administration (Oral Therapies and Subcutaneous Therapies) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World)The sleep apnea devices market is expected to reach USD 13.5 billion by 2023 anticipated to grow at a CAGR of 4.61% during the forecast period 2023-2035.

Sleep apnea, also referred to as sleep apnoea, is a serious sleep disorder characterized by recurrent pauses in breathing during sleep, which can persist for several minutes. It is categorized into three main types: obstructive sleep apnea, central sleep apnea, and complex sleep apnea. The most common types are obstructive sleep apnea and central sleep apnea, which share similar symptoms including loud snoring, morning headaches, excessive daytime sleepiness, and dry mouth.

Sleep apnea often goes undiagnosed and can affect individuals across all age groups. Obesity and excess weight are recognized as primary factors contributing to sleep apnea in adults, while lifestyle factors such as smoking, alcohol consumption, lack of physical activity, and psychological stress also play a role in its increasing prevalence. Healthcare professionals are increasingly focused on developing effective, safe, and versatile diagnostic and treatment options for sleep apnea. Currently, various therapeutic devices are utilized for its management. With the growing burden of sleep apnea and ongoing research efforts to enhance medical devices for obstructive sleep apnea, the sleep apnea devices market is expected to experience consistent growth in the foreseeable future.Report Coverage

The report comprehensively examines the sleep apnea devices market based on product type, type of diagnostic device, type of therapeutic device, type of positive airway pressure device, route of administration and key geographical regions.

It thoroughly analyzes market influences such as drivers, restraints, opportunities, and challenges, while evaluating competitive landscapes for top players. Forecasts are provided for segment revenues across major regions.

A thorough overview of sleep apnea is provided, covering its various types and the impact it has on health. The discussion also includes an overview of devices used for both diagnosing and treating sleep apnea, along with details on ongoing research into drug therapies for the condition.

An extensive evaluation of the market landscape for diagnostic devices used in detecting sleep apnea is conducted, considering parameters such as device type, monitored physiological parameters, diagnosed sleep apnea type, connectivity options, target patient segment, end users, and pricing. The chapter also includes information on device developers, analyzed based on parameters like establishment year, company size, and headquarters location.

An in-depth evaluation of the market landscape for therapeutic devices used in treating sleep apnea is carried out, considering parameters such as treated sleep apnea type, therapeutic principles, device type, mask type, treatment type, connectivity options, storage choices, target patient segment, end users, and pricing. The chapter also provides information on device developers, analyzed based on parameters like establishment year, company size, headquarters location, and identification of the most active players in terms of product development.

A comprehensive examination of the current market landscape for drug therapies targeting sleep apnea treatment is presented, considering parameters such as development phase, therapy type, administration route, dose count, and target patient segment. The chapter also includes information on therapy developers, analyzed based on parameters like establishment year, company size, and headquarters location.

Detailed profiles of leading companies in the sleep apnea market are presented, selected based on the strength of their product portfolios. Each profile includes an overview of the company, including establishment year, employee count, headquarters location, leadership team, product portfolio details, recent developments, and future outlook.

An insightful analysis of completed and ongoing clinical trials related to sleep apnea is conducted, considering parameters such as trial registration year, phase, status, sponsor/collaborator type, study design, focus area, patient enrollment count, and the most active players based on the number of trials conducted. Geographical considerations are also included.

An examination of partnerships within the sleep apnea market since 2017 is provided, covering various agreement types including acquisitions, product/technology integrations, distribution agreements, service alliances, commercialization agreements, research agreements, and others.

A detailed analysis of funding and investments in sleep apnea companies since 2019 is conducted, considering parameters such as investment year, amount, funding type, focus area, leading players, key investors, and geographical distribution.

An in-depth analysis of patents filed or granted related to sleep apnea since 2019 is presented, considering parameters such as patent type, publication year, jurisdiction, CPC symbols, applicant type, leading industry and non-industry players, leading individual assignees, along with a detailed patent benchmarking and valuation analysis highlighting leading patents based on citation count.

Key Market Companies

Acurable

Advanced Brain Monitoring

Airway Management

Apnimed

Bayer

Belun Technology

BRAEBON Medical

Cadwell

Desitin Pharma

Drive DeVilbiss Healthcare

Eli Lilly and Company

Hunan Ventmed Medical Technology

Incannex Healthcare

Löwenstein Medical

Nihon Kohden

Nox Medical

Oventus Medical

Philips

React Health

ResMed

SciSparc

Sibelmed

Somnetics International inc

SomnoMed

Sunrise

Topson Medical

Vyaire Medical

Wellue

Whole You

ZOLL Itamar

1. Preface: 1.1. Introduction; 1.2. Market Share Insights; 1.3. Key Market Insights; 1.4. Report Coverage; 1.5 Research Methodology; 1.6. Frequently Asked Questions; 1.7. Chapter Outlines
2. Research Methodology: 2.1. Chapter Overview; 2.2. Research Assumptions; 2.3. Project Methodology; 2.4. Forecast Methodology; 2.5. Robust Quality Control; 2.6. Key Market Segmentations; 2.7. Key Considerations; 2.7.1. Demographics; 2.7.2. Economic Factors; 2.7.3. Government Regulations; 2.7.4. Supply Chain; 2.7.5. Covid Impact / Related Factors; 2.7.6. Market Access; 2.7.7. Healthcare Policies; 2.7.8. Industry Consolidation
3. Economic And Other Project Specific Considerations: 3.1. Chapter Overview; 3.2. Market Dynamics; 3.2.1. Time Period; 3.2.1.1. Historical Trends; 3.2.1.2. Current And Future Estimates; 3.2.2. Currency Coverage; 3.2.2.1. Overview Of Major Currencies Affecting The Market; 3.2.2.2. Impact Of Currency Fluctuations On The Industry; 3.2.3. Foreign Exchange Impact; 3.2.3.1. Evaluation Of Foreign Exchange Rates And Their Impact On Market; 3.2.3.2. Strategies For Mitigating Foreign Exchange Risk; 3.2.4. Recession; 3.2.4.1. Historical Analysis Of Past Recessions And Lessons Learnt; 3.2.4.2. Assessment Of Current Economic Conditions And Potential Impact On The Market; 3.2.5. Inflation; 3.2.5.1. Measurement And Analysis Of Inflationary Pressures In The Economy; 3.2.5.2. Potential Impact Of Inflation On The Market Evolution
4. Executive Summary
5. Introduction: 5.1. Chapter Overview; 5.2. Introduction To Sleep Apnea; 5.3. Type Of Sleep Apnea; 5.3.1. Obstructive Sleep Apnea; 5.3.2. Central Sleep Apnea; 5.3.3. Complex Sleep Apnea; 5.4. The Impact Of Sleep Apnea On Health; 5.5. Diagnosis Of Sleep Apnea; 5.6. Treatment Of Sleep Apnea; 5.6.1. Therapeutic Devices For Sleep Apnea; 5.6.2. Drug Therapies For Sleep Apnea; 5.7. Concluding Remarks
6. Sleep Apnea Diagnostic Devices: Market Landscape: 6.1. Chapter Overview; 6.2. Sleep Apnea Diagnostic Devices: Overall Market Landscape; 6.2.1. Analysis By Type Of Device; 6.2.2. Analysis By Physiological Parameters Monitored; 6.2.3. Analysis By Type Of Sleep Apnea Diagnosed; 6.2.4. Analysis By Device Connectivity; 6.2.5. Analysis By Target Patient Segment; 6.2.6. Analysis By End User; 6.2.7. Analysis By Price; 6.3. Sleep Apnea Diagnostic Devices: Developer Landscape; 6.3.1. Analysis By Year Of Establishment; 6.3.2. Analysis By Company Size; 6.3.3. Analysis By Location Of Headquarters; 6.3.4. Analysis By Company Size And Location Of Headquarters
7. Sleep Apnea Therapeutic Devices: Market Landscape: 7.1. Chapter Overview; 7.2. Sleep Apnea Therapeutic Devices: Overall Market Landscape; 7.2.1. Analysis By Type Of Sleep Apnea Treated; 7.2.2. Analysis By Therapeutic Principle; 7.2.3. Analysis By Type Of Device; 7.2.4. Analysis By Type Of Mask; 7.2.5. Analysis By Type Of Treatment; 7.2.6. Analysis By Device Connectivity; 7.2.7. Analysis By Type Of Storage Offered; 7.2.8. Analysis By Target Patient Segment; 7.2.9. Analysis By End User; 7.2.10. Analysis By Price; 7.3. Sleep Apnea Therapeutic Devices: Developer Landscape; 7.3.1. Analysis By Year Of Establishment; 7.3.2. Analysis By Company Size; 7.3.3. Analysis By Location Of Headquarters; 7.3.4. Analysis By Company Size And Location Of Headquarters; 7.3.5. Most Active Players: Analysis By Number Of Products
8. Sleep Apnea Drug Therapies: Market Overview: 8.1. Chapter Overview; 8.2. Sleep Apnea Drug Therapies: Overall Market Landscape; 8.2.1. Analysis By Phase Of Development; 8.2.2. Analysis By Type Of Drug Therapy; 8.2.3. Analysis By Route Of Administration; 8.2.4. Analysis By Number Of Doses; 8.2.5. Analysis By Target Patient Segment; 8.3. Sleep Apnea: Developer Landscape (Industry Players); 8.3.1. Analysis By Year Of Establishment; 8.3.2. Analysis By Company Size; 8.3.3. Analysis By Location Of Headquarters; 8.3.4. Analysis By Company Size And Location Of Headquarters
9. Company Profiles: Sleep Apnea Diagnostic Device Developers: 9.1. Chapter Overview; 9.2. Cadwell; 9.2.1. Company Overview; 9.2.2. Device Portfolio; 9.2.3. Recent Developments And Future Outlook; 9.3. Itamar Medical; 9.3.1. Company Overview; 9.3.2. Device Portfolio; 9.3.3. Recent Developments And Future Outlook; 9.4. Nox Medical; 9.4.1. Company Overview; 9.4.2. Device Portfolio; 9.4.3. Recent Developments And Future Outlook; 9.5. Other Leading Diagnostic Device Developers; 9.5.1. Acurable; 9.5.2. Advanced Brain Monitoring; 9.5.3. Belun Technology; 9.5.4. Braebon Medical; 9.5.5. Nihon Kohden; 9.5.6. Sibelmed; 9.5.7. Sunrise; 9.5.8. Vyaire Medical; 9.5.9. Wellue
10. Company Profiles: Sleep Apnea Therapeutic Device Developers: 10.1. Chapter Overview; 10.2. Löwenstein Medical; 10.2.1. Company Overview; 10.2.2. Device Portfolio; 10.2.3. Recent Developments And Future Outlook; 10.3. Resmed; 10.3.1. Company Overview; 10.3.2. Device Portfolio; 10.3.3. Recent Developments And Future Outlook; 10.4. Somnomed; 10.4.1. Company Overview; 10.4.2. Device Portfolio; 10.4.3. Recent Developments And Future Outlook; 10.5. Other Leading Therapeutic Device Developers; 10.5.1. Airway Management; 10.5.2. Drive Devilbiss Healthcare; 10.5.3. Hunan Ventmed Medical Technology; 10.5.4. Oventus; 10.5.5. Philips; 10.5.6. React Health; 10.5.7. Somnetics International; 10.5.8. Topson Medical; 10.5.9. Whole You
11. Company Profiles: Sleep Apnea Drug Therapy Developers: 11.1. Chapter Overview; 11.2. Apnimed; 11.2.1. Company Overview; 11.2.2. Drug Therapy Portfolio; 11.2.3. Recent Developments And Future Outlook; 11.3. Desitin Pharma; 11.3.1. Company Overview; 11.3.2. Drug Therapy Portfolio; 11.3.3. Recent Developments And Future Outlook; 11.4. Incannex Healthcare; 11.4.1. Company Overview; 11.4.2. Drug Therapy Portfolio; 11.4.3. Recent Developments And Future Outlook; 11.5. Other Leading Drug Therapy Developers; 11.5.1. Bayer; 11.5.2. Eli Lilly And Company; 11.5.3. Scisparc
12. Clinical Trial Analysis: 12.1. Chapter Overview; 12.2. Scope And Methodology; 12.3. Sleep Apnea: Clinical Trial Analysis; 12.3.1. Analysis By Trial Registration Year; 12.3.2. Analysis By Trial Phase; 12.3.3. Analysis By Trial Status; 12.3.4. Analysis By Trial Registration Year And Trial Status; 12.3.5. Analysis By Type Of Sponsor / Collaborator; 12.3.6. Analysis By Study Design; 12.3.6.1. Analysis By Type Of Patient Allocation Model Used; 12.3.6.2. Analysis By Type Of Intervention; 12.3.6.3. Analysis By Type Of Trial Masking Adopted; 12.3.6.4. Analysis By Trial Purpose; 12.3.7. Analysis By Trial Focus Area; 12.3.8. Analysis Of Patients Enrolled By Trial Registration Year; 12.3.9. Analysis Of Patients Enrolled By Trial Phase; 12.3.10. Most Active Industry Players: Analysis By Number Of Clinical Trials; 12.3.11. Most Active Non-industry Players: Analysis By Number Of Clinical Trials; 12.3.12. Analysis Of Clinical Trials By Geography; 12.3.12.1. Analysis Of Clinical Trials By Geography And Trial Status; 12.3.12.2. Analysis Of Patients Enrolled By Trial Status And Geography
13. Partnerships And Collaborations: 13.1. Chapter Overview; 13.2. Partnership Models; 13.3. Sleep Apnea Therapies And Devices: Partnerships And Collaborations; 13.3.1. Analysis By Year Of Partnership; 13.3.2. Analysis By Type Of Partnership; 13.3.3. Analysis By Year And Type Of Partnership; 13.3.4. Analysis By Type Of Partner; 13.3.5. Most Active Players: Analysis By Number Of Partnerships; 13.3.6. Analysis By Geography; 13.3.6.1. Local And International Deals; 13.3.6.2. Intercontinental And Intracontinental Deals
14. Funding And Investment Analysis: 14.1. Chapter Overview; 14.2. Types Of Funding; 14.3. Sleep Apnea: Funding And Investment Analysis; 14.3.1. Analysis By Year Of Investment; 14.3.2. Analysis Of Amount Invested By Year; 14.3.3. Analysis By Type Of Funding; 14.3.4. Analysis Of Amount Invested By Type Of Funding; 14.3.5. Analysis Of Amount Invested By Year And Type Of Funding; 14.3.6. Analysis By Investment Focus Area; 14.3.7. Most Active Players: Analysis By Number Of Instances; 14.3.8. Most Active Players: Analysis By Amount Raised; 14.3.9. Analysis By Type Of Investor; 14.3.10. Leading Investors: Analysis By Number Of Funding Instances; 14.3.11. Analysis By Geography; 14.3.11.1. Analysis Of Instances By Geography; 14.3.11.2. Analysis Of Amount Invested By Geography
15. Patent Analysis: 15.1. Chapter Overview; 15.2. Scope And Methodology; 15.3. Sleep Apnea: Patent Analysis; 15.3.1. Analysis By Type Of Patent; 15.3.2. Analysis By Patent Publication Year; 15.3.3. Analysis By Type Of Patent And Patent Publication Year; 15.3.4. Analysis By Patent Jurisdiction; 15.3.5. Analysis By Cpc Symbols; 15.3.6. Analysis By Type Of Applicant; 15.3.7. Leading Industry Players: Analysis By Number Of Patents; 15.3.8. Leading Non-industry Players: Analysis By Number Of Patents; 15.3.9. Leading Individual Assignees: Analysis By Number Of Patents; 15.4. Sleep Apnea: Patent Benchmark Analysis; 15.4.1. Analysis By Patent Characteristics; 15.5. Patent Valuation Analysis
16. Market Impact Analysis: Drivers, Restraints, Opportunities And Challenges: 16.1. Chapter Overview; 16.2. Market Drivers; 16.3. Market Restraints; 16.4. Market Opportunities; 16.5. Market Challenges; 16.6. Conclusion
17. Global Sleep Apnea Market: 17.1. Chapter Overview; 17.2. Assumptions And Methodology; 17.3. Global Sleep Apnea Market, Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 17.3.1. Scenario Analysis; 17.4. Key Market Segmentations
18. Global Sleep Apnea Market By Type Of Product: 18.1. Chapter Overview; 18.2. Assumptions And Methodology; 18.3. Global Sleep Apnea Market: Distribution By Type Of Product, 2018, 2023 And 2035; 18.3.1. Sleep Apnea Medical Devices: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 18.3.2. Drug Therapies: Forecasted Estimates (2025-2035); 18.4. Data Triangulation And Validation
19. Global Sleep Apnea Diagnostic Devices Market: 19.1. Chapter Overview; 19.2. Assumptions And Methodology; 19.3. Scenario 1: Global Sleep Apnea Diagnostic Devices Market, Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 19.3.1. Scenario Analysis
20. Sleep Apnea Diagnostic Devices Market: Distribution By Type Of Diagnostic Device: 20.1. Chapter Overview; 20.2. Key Assumptions And Methodology; 20.3. Sleep Apnea Diagnostic Devices Market: Distribution By Type Of Diagnostic Device, 2018, 2023 And 2035; 20.3.1. Polysomnography Devices: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 20.3.2. Home Sleep Apnea Testing Devices: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 20.4. Data Triangulation And Validation
21. Sleep Apnea Diagnostic Devices Market: Distribution By Key Geographical Regions: 21.1. Chapter Overview; 21.2. Key Assumptions And Methodology; 21.3. Sleep Apnea Diagnostic Devices Market: Distribution By Key Geographical Regions, 2018, 2023 And 2035; 21.3.1. North America: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 21.3.2. Europe: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 21.3.3. Asia-pacific: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 21.3.4. Rest Of The World: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 21.4. Data Triangulation And Validation
22. Global Sleep Apnea Therapeutic Devices Market: 22.1. Chapter Overview; 22.2. Assumptions And Methodology; 22.3. Global Sleep Apnea Therapeutic Devices Market, Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 22.3.1. Scenario Analysis
23. Sleep Apnea Therapeutic Devices Market: Distribution By Type Of Therapeutic Device: 23.1. Chapter Overview; 23.2. Key Assumptions And Methodology; 23.3. Sleep Apnea Therapeutic Devices Market: Distribution By Type Of Therapeutic Device, 2018, 2023 And 2035; 23.3.1. Pap Devices: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 23.3.2. Oral Devices: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 23.3.3. Implanted Devices: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 23.4. Data Triangulation And Validation
24. Sleep Apnea Therapeutic Devices Market: Distribution By Type Of Pap Device: 24.1. Chapter Overview; 24.2. Key Assumptions And Methodology; 24.3. Sleep Apnea Therapeutic Devices Market: Distribution By Type Of Pap Device, 2018, 2023 And 2035; 24.3.1. Cpap Devices: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 24.3.2. Bipap Devices: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 24.3.3. Apap Devices: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 24.3.4. Other Devices: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 24.4. Data Triangulation And Validation
25. Sleep Apnea Therapeutic Devices Market: Distribution By Key Geographical Regions: 25.1. Chapter Overview; 25.2. Key Assumptions And Methodology; 25.3. Sleep Apnea Therapeutic Devices Market: Distribution By Key Geographical Regions, 2018, 2023 And 2035; 25.3.1. North America: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 25.3.2. Europe: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 25.3.3. Asia-pacific: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 25.3.4. Rest Of The World: Historical Trends (2018-2022) And Forecasted Estimates (2023-2035); 25.4. Data Triangulation And Validation
26. Global Sleep Apnea Drug Therapies Market: 26.1. Chapter Overview; 26.2. Assumptions And Methodology; 26.3. Global Sleep Apnea Drug Therapies Market: Forecasted Estimates (2025-2035); 26.3.1. Scenario Analysis; 26.4. Sleep Apnea Drug Therapies Market: Drug Therapy-wise Sales Forecast, 2025-2035
27. Sleep Apnea Drug Therapies Market: Distribution By Route Of Administration: 27.1. Chapter Overview; 27.2. Assumptions And Methodology; 27.3. Sleep Apnea Drug Therapies Market: Distribution By Route Of Administration, 2025 And 2035; 27.3.1. Oral Drug Therapies Market: Forecasted Estimates (2026-2035); 27.3.2. Subcutaneous Drug Therapies Market: Forecasted Estimates (2025-2035)
28. Sleep Apnea Drug Therapies Market: Distribution By Key Geographical Regions: 28.1. Chapter Overview; 28.2. Key Assumptions And Methodology; 28.3 Sleep Apnea Drug Therapies Market: Distribution By Key Geographical Regions, 2025 And 2035; 28.3.1. North America: Forecasted Estimates (2025-2035); 28.3.1.1. Us: Forecasted Estimates (2025-2035); 28.3.1.2. Mexico: Forecasted Estimates (2025-2035); 28.3.2. Europe: Forecasted Estimates (2026-2035); 28.3.2.1. Belgium: Forecasted Estimates (2027-2035); 28.3.2.2. Germany: Forecasted Estimates (2026-2035); 28.3.3. Asia-pacific: Forecasted Estimates (2026-2035); 28.3.3.1. Australia: Forecasted Estimates (2026-2035); 28.3.3.2. China: Forecasted Estimates (2026-2035); 28.3.3.3. Japan: Forecasted Estimates (2026-2035); 28.3.3.4. Taiwan: Forecasted Estimates (2026-2035); 28.3.4. Rest Of The World: Forecasted Estimates (2026-2035); 28.3.4.1. Brazil: Forecasted Estimates (2026-2035)
29. Conclusion
30. Appendix 1: Tabulated Data
31. Appendix 2: List Of Companies And Organizations

Pricing

Currency Rates

PDF Email from Publisher – One User License $4,799
PDF Email from Publisher – Consulting Company Team License $8,999
PDF Email from Publisher – Department License $10,599
PDF Email from Publisher – Global Site License for One Company $17,999

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now